Research Activities for Next Generation Sequencing Accelerate, New Studies
Outline Efficacy on Treating Fatal Conditions
By Pratik Kirve, Allied Analytics
Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction. In April, FDA finalized two guidance documents to speed up development of NGS-based tests.